{
    "root": "280c139f-c3a2-46e4-b990-ce3808166e86",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Gabapentin"
    },
    "value": "20250502",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POLOXAMER 407",
            "code": "TUF2IVW3M2"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        }
    ],
    "indications": "Gabapentin is indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications": "Postherpetic Neuralgia ( 2.1 ) o Dose can be titrated up as needed to a dose of 1800 mg/day o Day 1: Single 300 mg dose o Day 2: 600 mg/day (i.e., 300 mg two times a day) o Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three  times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "Gabapentin tablets, USP are supplied as follows:\n                  \n                  600 mg tablets:\n                  White to off white elliptical film coated tablets with \"G/6\" debossed on one side and scored on both sides, available in:\n                  Bottles of 100: NDC 67877-428-01\n                  Bottles of 500: NDC 67877-428-05\n                  Bottles of 1000: NDC 67877-428-10\n                  One Carton of 100 (10 x 10 Unit-dose Tablets): NDC 67877-428-38\n                  800 mg tablets:\n                  White to off white elliptical film coated tablets with \"G/8\" debossed on one side and scored on both sides, available in:\n                  Bottles of 100: NDC 67877-429-01\n                  Bottles of 500: NDC 67877-429-05\n                  Bottles of 1000: NDC 67877-429-10\n                  One Carton of 100 (10 x 10 Unit-dose Tablets): NDC 67877-429-38\n                  \n                  Store at 20º to 25ºC (68º to 77ºF); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].",
    "adverseReactions": "Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}